Biotech · Public company · Austin, TX, US

Rein Therapeutics, Inc.

Ticker RNTX · SEC CIK 0001420565

Track this companyFree. Adds Rein Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials31 recruiting or active

Pipeline programs4From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline4

Dry Powder InhalerPhase 2 · Idiopathic Pulmonary Fibrosis (IPF)ClinicalTrials.gov · fetched Nov 12, 2026
LTI-01Phase 2 · Pleural EffusionClinicalTrials.gov · fetched Nov 12, 2026
LTI-03Phase 2 · Idiopathic Pulmonary Fibrosis (IPF)ClinicalTrials.gov · fetched Nov 12, 2026
LTI-03Phase 1 · Idiopathic Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary FibrosisPHASE2 · RECRUITING · started Feb 2, 2026ClinicalTrials.gov NCT06968845 · fetched Nov 12, 2026
A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) PatientsPHASE1 · COMPLETED · started Jul 6, 2023ClinicalTrials.gov NCT05954988 · fetched Nov 12, 2026
A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural EffusionsPHASE2 · COMPLETED · started Sep 26, 2020ClinicalTrials.gov NCT04159831 · fetched Nov 12, 2026